Polyethylene Glycol-3350 and Electrolytes (Novel Laboratories, Inc.)
Welcome to the PulseAid listing for the Polyethylene Glycol-3350 and Electrolytes drug offered from Novel Laboratories, Inc.. This Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novel Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Polyethylene Glycol-3350 and Electrolytes |
| SUBSTANCE NAME: | POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; SODIUM SULFATE ANHYDROUS |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2009-06-01 |
| END MARKETING DATE: | 0000-00-00 |
Polyethylene Glycol-3350 and Electrolytes HUMAN PRESCRIPTION DRUG Details:
| Item Description | Polyethylene Glycol-3350 and Electrolytes from Novel Laboratories, Inc. |
| LABELER NAME: | Novel Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 236; 5.86; 6.74; 2.97; 22.74(g/274.31g; g/274.31g; g/274.31g; g/274.31g; g/274.31g) |
| START MARKETING DATE: | 2009-06-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 40032-090_d6e9f30d-5ff9-45bc-8a0d-3e7eacb560d7 |
| PRODUCT NDC: | 40032-090 |
| APPLICATION NUMBER: | ANDA090231 |
Other POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE; SODIUM SULFATE ANHYDROUS Pharmaceutical Manufacturers / Labelers:
